Related Experiment Video

Updated: Aug 29, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model

R Vink1, R A Kraaijenhagen, M Levi

  • 1Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. r.vink@amc.uva.nl

Journal of Thrombosis and Haemostasis : JTH
|December 17, 2003
PubMed

Insights

Optimizing anticoagulant therapy for deep vein thrombosis (DVT) requires balancing treatment benefits against bleeding risks. Individualized treatment duration, based on a patient's unique recurrence and bleeding risk, is key for effective DVT management.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • The optimal duration of oral anticoagulant therapy following a first deep vein thrombosis (DVT) episode remains debated.
  • Current guidelines stratify treatment duration based on risk factors, primarily focusing on recurrence risk while minimally considering bleeding risk.

Purpose of the Study:

  • To optimize anticoagulant treatment strategies using vitamin K antagonists for individual DVT patients.
  • To develop a model that balances the risks of recurrent venous thromboembolism (VTE) against major bleeding complications.

Main Methods:

  • An extensive literature review was conducted to construct a mathematical model.
  • The model incorporates parameters such as baseline VTE and bleeding risk factors, DVT clinical course, and vitamin K antagonist efficacy.
  • Individualized risks for recurrent VTE and bleeding episodes are calculated to determine optimal treatment duration.

Main Results:

  • The model allows for the calculation of individual patient risks for VTE recurrence and bleeding.
  • Optimal anticoagulant therapy duration is defined as the point where VTE prevention benefits are outweighed by bleeding risks.

Conclusions:

  • Determining the appropriate duration of anticoagulant treatment involves balancing therapeutic benefits against treatment risks.
  • The study highlights that optimal DVT treatment duration is highly patient-specific, depending on individual bleeding and recurrence risk profiles.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...